Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis
Banafsheh Hosseini, Asmae El Abd, Francine M Ducharme
Nutrients, doi:10.3390/nu14102134
The COVID-19 outbreak has rapidly expanded to a global pandemic; however, our knowledge is limited with regards to the protective factors against this infection. The aim of this systematic literature review and meta-analysis was to evaluate the impact of vitamin D supplementation on COVID-19 related outcomes. A systematic search of relevant papers published until January 2022 was conducted to identify randomized controlled trials (RCTs) and non-randomized studies of intervention (NRISs). The primary outcomes included the risk of COVID-19 infection (primary prevention studies on uninfected individuals), hospital admission (secondary prevention studies on mild COVID-19 cases), and ICU admission and mortality rate (tertiary prevention studies on hospitalized COVID-19 patients). We identified five studies (one RCT, four NRISs) on primary prevention, with five (two RCTs, three NRISs) on secondary prevention, and 13 (six RCTs, seven NRISs) on tertiary prevention. Pooled analysis showed no significant effect on the risk of COVID-19 infection. No meta-analysis was possible on hospitalization risk due to paucity of data. Vitamin D supplementation was significantly associated with a reduced risk of ICU admission (RR = 0.35, 95% CI: 0.20, 0.62) and mortality (RR = 0.46, 95% CI: 0.30, 0.70). Vitamin D supplementation had no significant impact on the risk of COVID-19 infection, whereas it showed protective effects against mortality and ICU admission in COVID-19 patients.
Author Contributions: B.H. designed the study, performed the literature search and statistical analysis, and drafted the manuscript. B.H. and A.E.A. performed data extraction and assessed the quality of the included studies. F.M.D. supervised the conduct of this review from inception to analysis and edited the manuscript. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement: Not Applicable. Informed Consent Statement: Not Applicable.
Conflicts of Interest: The authors declare no conflict of interest.
References
Abdulateef, Rahman, Salih, Osman, Mahmood et al., COVID-19 severity in relation to sociodemographics and vitamin D use, Open Med,
doi:10.1515/med-2021-0273Alcala-Diaz, Limia-Perez, Gomez-Huelgas, Martin-Escalante, Cortes-Rodriguez et al., Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study, Nutrients,
doi:10.3390/nu13061760Annweiler, Beaudenon, Simon, Guenet, Otekpo et al., Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study, J. Steroid Biochem. Mol. Biol,
doi:10.1016/j.jsbmb.2021.105958Annweiler, Corvaisier, Gautier, Dubée, Legrand et al., Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study, Nutrients,
doi:10.3390/nu12113377Annweiler, Hanotte, De L'eprevier, Sabatier, Lafaie et al., Vitamin D and survival in COVID-19 patients: A quasi-experimental study, J. Steroid Biochem. Mol. Biol,
doi:10.1016/j.jsbmb.2020.105771Butler-Laporte, Nakanishi, Mooser, Morrison, Abdullah et al., Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study, PLoS Med,
doi:10.1371/journal.pmed.1003605Caballero-García, Pérez-Valdecantos, Guallar, Caballero-Castillo, Roche et al., Effect of Vitamin D Supplementation on Muscle Status in Old Patients Recovering from COVID-19 Infection, Medicina
Cangiano, Fatti, Danesi, Gazzano, Croci et al., Mortality in an Italian nursing home during COVID-19 pandemic: Correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests, Aging,
doi:10.18632/aging.202307Castillo, Costa, Barrios, Díaz, Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J. Steroid Biochem. Mol. Biol,
doi:10.1016/j.jsbmb.2020.105751Cereda, Bogliolo, Lobascio, Barichella, Zecchinelli et al., Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy, Nutrition
Chen, Wan, Han, Li, Zhang et al., Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: A meta-analysis of randomized controlled trials, Nutrients,
doi:10.3390/nu6062206Deeks, Altman, Chapter 10: Analysing data and undertaking meta-analyses
Giannini, Passeri, Tripepi, Sella, Fusaro et al., Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study, Nutrients,
doi:10.3390/nu13010219Güven, Gültekin, The effect of high-dose parenteral vitamin D3 on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: An observational cohort study, Eur. J. Clin. Nutr
Handu, Comparison of the Academy of Nutrition and Dietetics updated Quality Criteria Checklist and Cochrane's ROB 2.0 as risk of bias tools
Hernández, Nan, Fernandez-Ayala, García-Unzueta, Hernández-Hernández et al., Vitamin D Status in Hospitalized Patients with SARS-CoV-2
Higgins, Page, Elbers, Sterne, Chapter 8: Assessing risk of bias in a randomized trial
Hosseini, Tremblay, Longo, Golchi, White et al., Prevention of COVID-19 with Oral Vitamin D Supplemental Therapy in Essential healthCare Teams (PROTECT): Ancillary Study of a Randomized Controlled Trial
Jolliffe, Camargo, Sluyter, Aglipay, Aloia et al., Vitamin D supplementation to prevent acute respiratory infections: A systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(21)00051-6Lakkireddy, Gadiga, Malathi, Karra, Raju et al., Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease, Sci. Rep,
doi:10.1038/s41598-021-90189-4Ling, Broad, Murphy, Pappachan, Pardesi-Newton et al., High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study, Nutrients,
doi:10.3390/nu12123799Ma, Zhou, Heianza, Qi, Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: A prospective study in UK Biobank, Am. J. Clin. Nutr,
doi:10.1093/ajcn/nqaa381Meltzer, Best, Zhang, Vokes, Arora et al., Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results, JAMA Netw. Open,
doi:10.1001/jamanetworkopen.2020.19722Moher, Liberati, Tetzlaff, Altman, The, Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement, J. Clin. Epidemiol,
doi:10.1016/j.jclinepi.2009.06.005Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients with Moderate to Severe COVID-19: A Randomized Clinical Trial, JAMA,
doi:10.1001/jama.2020.26848Nikniaz, Akbarzadeh, Hosseinifard, Hosseini, The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis, MedRxiv,
doi:10.34172/PS.2021.13Nogues, Ovejero, Pineda-Moncusí, Bouillon, Arenas et al., Calcifediol treatment and COVID-19-related outcomes, J. Clin. Endocrinol. Metab,
doi:10.1210/clinem/dgab405Nogués, Diana, Quesada-Gomez, Bouillon, Arenas et al., Calcifediol Treatment and COVID-19-Related Outcomes
Oristrell, Oliva, Subirana, Casado, Domínguez et al., Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study, Biomedicines,
doi:10.3390/biomedicines9050509Page, Sterne, Chapter 13: Assessing risk of bias due to missing results in a synthesis
Pal, Banerjee, Bhadada, Shetty, Singh et al., Vitamin D supplementation and clinical outcomes in COVID-19: A systematic review and meta-analysis, J. Endocrinol. Investig,
doi:10.1007/s40618-021-01614-4Pereira, Dantas Damascena, Galvão Azevedo, De Almeida Oliveira, Da Mota Santana, Vitamin D deficiency aggravates COVID-19: Systematic review and meta-analysis, Crit. Rev. Food Sci. Nutr,
doi:10.1080/10408398.2020.1841090Rastogi, Bhansali, Khare, Suri, Yaddanapudi et al., Short term, high-dose vitamin D supplementation for COVID-19 disease: A randomised, placebo-controlled, study (SHADE study), Postgrad. Med. J,
doi:10.1136/postgradmedj-2020-139065Rawat, Roy, Maitra, Shankar, Khanna et al., Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis, Diabetes Metab. Syndr. Clin. Res. Rev,
doi:10.1016/j.dsx.2021.102189Reeves, Deeks, Higgins, Shea, Chapter 24: Including non-randomized studies on intervention effects
Sabico, Enani, Sheshah, Aljohani, Aldisi et al., Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial, Nutrients,
doi:10.3390/nu13072170Shah, Saxena, Mavalankar, Vitamin D supplementation, COVID-19 and disease severity: A meta-analysis, QJM Int. J. Med,
doi:10.1093/qjmed/hcab009Sánchez-Zuno, González-Estevez, Matuz-Flores, Macedo-Ojeda, Hernández-Bello et al., Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation, J. Clin. Med,
doi:10.3390/jcm10112378Worldometer, None
